folinic acid leucovorin
Selected indexed studies
- Leucovorin (folinic acid) rescue for high-dose methotrexate: A review. (J Clin Pharm Ther, 2022) [PMID:35929573]
- Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. (Mol Psychiatry, 2018) [PMID:27752075]
- Folinic acid improves the score of Autism in the EFFET placebo-controlled randomized trial. (Biochimie, 2020) [PMID:32387472]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Safety and Efficacy of High-Dose Folinic Acid in Children with Autism: The Impact of Folate Metabolism Gene Polymorphisms. (2025) pubmed
- Leucovorin (folinic acid) rescue for high-dose methotrexate: A review. (2022) pubmed
- Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. (2018) pubmed
- Folinic acid improves the score of Autism in the EFFET placebo-controlled randomized trial. (2020) pubmed
- Navigating methotrexate toxicity: Examining the therapeutic roles of folinic acid and glucarpidase. (2025) pubmed
- Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial. (2021) pubmed
- Folinic acid as a treatment for autism in children: A within-subjects open-label study on safety and efficacy. (2025) pubmed
- Clinical concerns and considerations for leucovorin use in autism spectrum disorder. (2026) pubmed
- Effects of leucovorin (folinic acid) in the methotrexate-treated rat brain. (2018) pubmed
- Folinic acid-responsive neonatal seizures. (1999) pubmed